These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25047815)

  • 1. Ghrelin receptor modulators: a patent review (2011 - 2014).
    Costantino L; Barlocco D
    Expert Opin Ther Pat; 2014 Sep; 24(9):1007-19. PubMed ID: 25047815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in ghrelin receptor ligands.
    Moulin A; Ryan J; Martinez J; Fehrentz JA
    ChemMedChem; 2007 Sep; 2(9):1242-59. PubMed ID: 17520591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists.
    Pasternak A; Goble SD; deJesus RK; Hreniuk DL; Chung CC; Tota MR; Mazur P; Feighner SD; Howard AD; Mills SG; Yang L
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6237-40. PubMed ID: 19767208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone secretagogue receptor antagonists.
    Costantino L
    Expert Opin Ther Pat; 2012 Jun; 22(6):697-700. PubMed ID: 22537050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists.
    McCoull W; Barton P; Brown AJ; Bowker SS; Cameron J; Clarke DS; Davies RD; Dossetter AG; Ertan A; Fenwick M; Green C; Holmes JL; Martin N; Masters D; Moore JE; Newcombe NJ; Newton C; Pointon H; Robb GR; Sheldon C; Stokes S; Morgan D
    J Med Chem; 2014 Jul; 57(14):6128-40. PubMed ID: 24967667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin receptor modulators and their therapeutic potential.
    Costantino L; Barlocco D
    Future Med Chem; 2009 Apr; 1(1):157-77. PubMed ID: 21426074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors (WO2012035124): a patent evaluation.
    Costantino L
    Expert Opin Ther Pat; 2012 Sep; 22(9):1099-104. PubMed ID: 22809244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases.
    Sanger GJ
    Drug Discov Today; 2008 Mar; 13(5-6):234-9. PubMed ID: 18342799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin Receptor Ligands Reaching Clinical Trials: From Peptides to Peptidomimetics; from Agonists to Antagonists.
    Vodnik M; Štrukelj B; Lunder M
    Horm Metab Res; 2016 Jan; 48(1):1-15. PubMed ID: 26551992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments around histamine H(3) receptor antagonists/inverse agonists: a patent review (2010 - present).
    Łażewska D; Kieć-Kononowicz K
    Expert Opin Ther Pat; 2014 Jan; 24(1):89-111. PubMed ID: 24131059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor.
    Kung DW; Coffey SB; Jones RM; Cabral S; Jiao W; Fichtner M; Carpino PA; Rose CR; Hank RF; Lopaze MG; Swartz R; Chen HT; Hendsch Z; Posner B; Wielis CF; Manning B; Dubins J; Stock IA; Varma S; Campbell M; DeBartola D; Kosa-Maines R; Steyn SJ; McClure KF
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4281-7. PubMed ID: 22677316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays.
    Sturaro C; Ruzza C; Ferrari F; Pola P; Argentieri M; Frezza A; Marzola E; Bettegazzi B; Cattaneo S; Pietra C; Malfacini D; Calò G
    Eur J Pharmacol; 2024 Oct; 981():176880. PubMed ID: 39128804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, evaluation, and comparison of ghrelin receptor agonists and inverse agonists as suitable radiotracers for PET imaging.
    Chollet C; Bergmann R; Pietzsch J; Beck-Sickinger AG
    Bioconjug Chem; 2012 Apr; 23(4):771-84. PubMed ID: 22372770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 1,2,4-triazole as a scaffold for the design of ghrelin receptor ligands: development of JMV 2959, a potent antagonist.
    Moulin A; Brunel L; Boeglin D; Demange L; Ryan J; M'Kadmi C; Denoyelle S; Martinez J; Fehrentz JA
    Amino Acids; 2013 Feb; 44(2):301-14. PubMed ID: 22798076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of agonism and inverse agonism in ghrelin receptor.
    Qin J; Cai Y; Xu Z; Ming Q; Ji SY; Wu C; Zhang H; Mao C; Shen DD; Hirata K; Ma Y; Yan W; Zhang Y; Shao Z
    Nat Commun; 2022 Jan; 13(1):300. PubMed ID: 35027551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ghrelin signaling in the gut, its physiological properties, and therapeutic potential.
    Avau B; Carbone F; Tack J; Depoortere I
    Neurogastroenterol Motil; 2013 Sep; 25(9):720-32. PubMed ID: 23910374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Optimization of Ghrelin Receptor Inverse Agonists to Improve Lipophilicity and Avoid Mechanism-Based CYP3A4 Inactivation.
    Takahashi B; Funami H; Shibata M; Maruoka H; Koyama M; Kanki S; Muto T
    Chem Pharm Bull (Tokyo); 2015; 63(10):825-32. PubMed ID: 26423040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptor.
    McClure KF; Jackson M; Cameron KO; Kung DW; Perry DA; Orr ST; Zhang Y; Kohrt J; Tu M; Gao H; Fernando D; Jones R; Erasga N; Wang G; Polivkova J; Jiao W; Swartz R; Ueno H; Bhattacharya SK; Stock IA; Varma S; Bagdasarian V; Perez S; Kelly-Sullivan D; Wang R; Kong J; Cornelius P; Michael L; Lee E; Janssen A; Steyn SJ; Lapham K; Goosen T
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5410-4. PubMed ID: 23953189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ghrelin as a target for gastrointestinal motility disorders.
    Greenwood-Van Meerveld B; Kriegsman M; Nelson R
    Peptides; 2011 Nov; 32(11):2352-6. PubMed ID: 21453735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motilin and ghrelin as prokinetic drug targets.
    De Smet B; Mitselos A; Depoortere I
    Pharmacol Ther; 2009 Aug; 123(2):207-23. PubMed ID: 19427331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.